BioSystem Development Launches its AssayMAP(TM) MAb Titer Assay for Rapid, High-throughput Antibody Measurement in Bioprocess Samples

Published: Dec 09, 2009

MADISON, Wis.--(BUSINESS WIRE)--BioSystem Development, LLC., a privately held life science analytics company, announces the release of the AssayMAP MAb Titer Assay for measuring antibody product concentrations (or titers) in bioprocess samples.

Back to news